Yüklüyor......
Radiation-agent combinations for glioblastoma: challenges in drug development and future considerations
Glioblastoma is an aggressive disease characterized by moderate initial response rates to first-line radiation-chemotherapy intervention followed by low poor response rates to second-line intervention. This article discusses novel strategic platforms for the development of radiation-investigational...
Kaydedildi:
| Yayımlandı: | J Neurooncol |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5709276/ https://ncbi.nlm.nih.gov/pubmed/28560665 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-017-2458-0 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|